MONTREAL, May 15 /CNW Telbec/ - Haemacure Corporation (TSX:HAE), a
Montreal-based specialty bio-therapeutics company developing high-value human
plasma-derived protein products for commercialization, announced today the
appointment of Reinaldo M. Diaz as a new member of the Board of Directors' of
the Company.
